Uterine Cancer

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

ISBN: 9780824759513 | 0824759516
Cover: Hardcover
Copyright: 9/23/2005

Rent

(Recommended)

$136.27

Term

Due

Price

Semester

Dec 13

$151.41

Quarter

Sep 13

$143.84

Short Term

Aug 16

$136.27

*This item is part of an exclusive publisher rental program and requires an additional convenience fee. This fee will be reflected in the shopping cart.
Buy Used

Usually Ships in 2-4 Business Days

$154.35
Buy New

Usually Ships in 3-5 Business Days

$206.86
eBook

Available Instantly

Online: 180 Days

Downloadable: 180 Days

$43.29

(Taylor & Francis) Third author, Andrew Burchuck, is with Duke Univ. Medical Center, Durham, NC. Reviews present knowledge in all aspects of uterine cancer with authoritative predictions on future directions in management. Discusses staging criteria, imaging techniques used in assessment and management, therapeutic regimens, HRT, and more. For researchers and clinicians.

Preface

iii

Contributors

1. Epidemiology

(12)

David M. Purdie

Incidence and Mortality

(1)

Cancer Subtypes

(1)

Risk Factors for Endometrial Cancer

(4)

References

(7)

2. Screening in Endometrial Cancer

(18)

Thomas Hogberg

What Does Cancer Screening Actually Mean?

(1)

Cancer Screening Traps

(1)

Screening for Endometrial Cancer?

(1)

Screening Tests for Endometrial Cancer

(2)

What Could Be Gained by Screening for Endometrial Cancer?

(1)

The Natural Course of Endometrial Cancer—Premalignant Conditions?

(3)

Risk Groups

(1)

Preliminary Screening Trials

(4)

Conclusions

(1)

References

(5)

3. Pathology of Endometrial Hyperplasia and Neoplasia

(22)

Terry Rollason and Raji Ganesan

Introduction

(3)

Endometrioid Carcinoma

(4)

Mucinous Carcinoma

(1)

Serous Carcinomas

(2)

Clear Cell Carcinoma

(1)

Mixed Carcinomas

(1)

Undifferentiated Carcinoma

(1)

Other Rare Types of Endometrial Carcinoma

(1)

Tumors Metastatic to the Endometrium

(6)

References

(4)

4. Pathology of Uterine Sarcoma

(16)

Nafisa Wilkinson

Introduction

(1)

Staging of Uterine Sarcomas

(1)

Endometrial Stromal Sarcoma

(4)

Immunohistochemistry of Uterine Sarcomas

(1)

Hormonal Aspects of Stromal Sarcomas

(2)

Myxoid Leiomyosarcoma

(1)

Epithelioid Leiomyosarcoma

(1)

Carcinosarcoma: A Metaplastic Carcinoma or Sarcoma?

(1)

Pure Sarcomas

(1)

Tamoxifen and its Role in Uterine Sarcoma

(1)

References.

(6)

5. The Molecular Genetics of Endometrial Cancer

(22)

G. Larry Maxwell, John I. Risinger, J. Carl Barrett, and Andrew Berchuck

Introduction

(1)

Somatic Genetic Alterations.

(6)

Hereditary Endometrial Cancer

(1)

Epigenetics in Endometrial Carcinoma

(4)

Microarray

(1)

Summary of the Molecular Biology of Endometrial Cancer

(2)

References

(8)

6. Clinical Presentation and Investigation: The "One-Stop" Clinic, Endometrial Sampling, Hysteroscopy, Vaginal Ultrasound

(16)

Christopher Lee and Davor Jurkovic

Introduction

(1)

Investigations

(5)

The Rapid Access Clinic

(3)

Conclusion

100

(1)

References

100

(7)

7. Imaging Endometrial Cancer

107

(24)

Moji Balogun and Julie Olliff

Magnetic Resonance Imaging

112

(14)

References

126

(5)

8. Surgery for Uterine Cancer

131

(18)

Neville F. Hacker and Donald E. Marsden

Endometrial Cancer

131

(2)

Prognostic Factors That May Help Determine the Appropriate Surgery for Endometrial Cancer

133

(3)

Diagnosis

136

(1)

Preoperative Work Up

137

(1)

The Surgical Procedure

137

(5)

Uterine Sarcomas

142

(2)

Summary

144

(1)

References

144

(5)

9. Risk Factors and the Role of Radiotherapy in the Treatment of Endometrial Cancer

149

(28)

Ida Ackerman and Helen Steed

History of Radiation

149

(1)

Staging and Prognostic Factors

150

(3)

Stage I Disease

153

(7)

Stage II Disease

160

(1)

Stage III and IV Disease

161

(4)

Palliative Radiotherapy

165

(1)

Uterine Papillary Serous Carcinoma

165

(1)

Uterine Sarcomas

166

(1)

Irradiation Technique and Dose

166

(1)

Radiotherapy Toxicity

167

(1)

Conclusions

168

(1)

References

168

(9)

10. Chemotherapy for Uterine Cancer

177

(22)

Kathryn F. Chrystal, Kerry A. Cheong, and Peter G. Harper

Introduction

177

(1)

Endometrioid Adenocarcinoma

178

(4)

Conclusion.

182

(1)

Serous Carcinoma

182

(2)

Uterine Sarcomas

184

(4)

Conclusions

188

(1)

References

188

(11)

11. Minimal Access Surgery in Endometrial Cancer

199

(12)

Robbert Soeters and Lynette Denny

Introduction

199

(1)

The Role of Vaginal Hysterectomy in the Management of Endometrial Cancer

200

(1)

Laparoscopic-Assisted Vaginal Hysterectomy (LAVH)

200

(1)

Laparoscopic Lymphadenectomy

201

(1)

Application of LAVH and Lymphadenectomy for Endometrial Cancer

201

(1)

Complications of Laparoscopy

202

(1)

Clinical Outcome of Laparoscopic Versus Open Abdominal Surgical Approach to Management of Endometrial Cancer

203

(1)

Cost Benefit of Laparoscopic Surgery

203

(1)

Contraindications to Laparoscopic Surgery for Treatment of Endometrial Cancer

204

(1)

Setting up for Laparoscopic Surgery

204

(1)

Laparoscopic Surgery

205

(3)

References

208

(3)

12. Follow-Up and Detection of Relapsed Disease in Uterine Cancer

211

(22)

Fabio Landoni, Angelo Maggioni, and Guilherme Cidade Crippa

Background

211

(2)

Patterns of Recurrence

213

(3)

Recurrence Risk Groups.

216

(2)

Prognosis After Recurrence

218

(2)

Detection and Surveillance

220

(8)

Conclusions

228

(3)

References

231

(2)

13. The Role of Surgery in Advanced and Relapsed Disease

233

(10)

J. Michael Straughn and Ronald D. Alvarez

Importance of Surgical Staging

233

(1)

Role of Radical Hysterectomy

234

(1)

Role of Primary Cytoreduction in Patients with Advanced Disease

235

(3)

Role of Secondary Cytoreduction in Patients with Relapsed Disease

238

(1)

Role of Pelvic Exenteration in Patients with Relapsed Disease

239

(1)

Conclusion

239

(1)

References

240

(3)

14. Endometrial Carcinoma and Hormone Replacement Therapy

243

(12)

Michael S. Marsh

Endometrial Cancer and Unopposed Estrogen Use

243

(1)

Vaginal Estrogen Treatment

244

(1)

The Addition of Progestogens

245

(3)

Tibolone and Endometrial Cancer Risk

248

(1)

Selective Estrogen Receptor Modulators (SERMs)

249

(1)

ERT Use in Women with Previous Endometrial Carcinoma.

249

(2)

Summary Points

251

(1)

References

251

(4)

15. Future Developments in Radiation Therapy for Endometrial Carcinoma

255

(12)

Carien L. Creutzberg and Jan G. Aalders

Reducing Indications for Pelvic Radiotherapy

256

(1)

The Role of Lymphadenectomy and Its Combination with Radiotherapy

257

(1)

The Increasing Use of Vaginal Brachytherapy Alone

258

(1)

The Use of Both Adjuvant Radiotherapy and Chemotherapy in High-Risk Disease

259

(2)

The Use of New RT Techniques to Reduce Morbidity

261

(1)

Conclusions

262

(1)

References

262

(5)

16. Future Directions: Chemotherapy and Novel Agents for Uterine Cancer

267

(14)

Stacy D. D'Andre and Karl C. Podratz

Introduction

267

(1)

Adjuvant Chemotherapy

268

(1)

Combined Modality Therapy: Radiosensitizing Chemotherapy

268

(1)

Chemotherapy for Advanced Disease

268

(2)

Paclitaxel

270

(1)

Topotecan

271

(1)

Doxil®

271

(1)

Docetaxel

271

(1)

Oxaliplatin

272

(1)

Novel Agents

272

(2)

Conclusions

274

(1)

References

274

(7)

17. Combined Therapy in Uterine Cancer: Future Directions

281

(10)

Howard D. Homesley

Whole Abdominal Radiation Versus Chemotherapy

281

(1)

High-Risk Stage I Endometrial Carcinoma

282

(1)

Hormonal Therapy

283

(2)

The GOG Chemotherapy Trials in Endometrial Cancer

285

(1)

Alternative Chemotherapy Combinations

285

(2)

Current GOG Combined Radiation and Chemotherapy Trial

287

(1)

Combined Hormonal, Chemotherapy, and Radiation Therapy

287

(1)

References

288

(3)

Index

291

Please wait while the item is added to your bag...

FREE SHIPPING

Amazon no longer offers textbook rentals. We do!

Uterine Cancer

Summary

Table of Contents

Supplemental Materials